Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Head-to-head
CoreAge Rx vs Kova
CoreAge Rx and Kova both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxKova
Ranked #226 · Grade C
Best for: Someone deciding between three, six and twelve months who wants the totals to be trustworthy.
Visit KovaThe verdict
CoreAge Rx edges out Kova on the Rx-Readiness Score, 95 to 51 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Kova is still a genuine option — kova is the rare site where the arithmetic is already done and comes out right. "3-month plan: $179/month, or $537 upfront" — and $179 × 3 is $537 exactly, which holds for all eight of its plans. That matters because plenty of sellers advertise a per-month figure that is really an average with a one-off discount folded in; these are not. Month to month, the number to plan around is the renewal: $299 for semaglutide, $399 for tirzepatide, after a cheaper first month. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Kova |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 51/100 · C |
| Overall rank | #1 | #226 |
| Semaglutide | $99/mo | $299/mo after the first month on the one-month plan |
| Tirzepatide | $149/mo | $399/mo after the first month on the one-month plan |
| Coverage | All 50 states | Not published on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Kova
Ranked #226 · Grade C
What we like
- The whole ladder is published in plain sentences, renewal rate included
- Per-month figures are true per-month figures: every upfront total is exactly the monthly rate times the term
- The term plans can be paid monthly rather than as a lump sum
The caveats
- The low prices require a term commitment — $129/mo for semaglutide means twelve months
- Month to month the price rises after month one: $249 to $299 for semaglutide, $299 to $399 for tirzepatide
- No list of states served
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Kova against other providers on our shortlist.
Or browse the full comparison hub.